JCSE01.23 Specific TP53 Mutation Subtypes as Biomarker for Response to PD-1/L1 Blockade Immunotherapy in NSCLCH. Sun,S. Liu,J.Y. Zhou,M. Zheng, J.J. Huan,Y.F. Guan,R. Gao,X. Yi,Y. WuJOURNAL OF THORACIC ONCOLOGY（2019）引用 1|浏览16暂无评分关键词NSCLC,PD-1/L1 blockade,TP53 subtypeAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
